BHAGERIANSEBhageria Industries LimitedHighNeutral
Announced Sat, 2 May · 13:11 IST

Bhageria Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Revenue Growth 20pctPat Growth 25pctResults View source PDF

BHAGERIA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.6%1-day move
₹172.50
prior close
₹174.18
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1-0.1-0.5-4.6-2.1-2.1-3.5-6.0-9.0-10.1+8.7+23.5
Up moveDown movePending
AI summary

Bhageria Industries reported strong full-year results for FY2026 with standalone revenue from operations growing 45.9% to Rs 87,143.39 Lakhs from Rs 59,715.90 Lakhs in FY2025. Standalone profit after tax increased 19% to Rs 5,029.85 Lakhs versus Rs 4,226.54 Lakhs in the prior year. The Board recommended a dividend of Rs 2.50 per share (50% on face value of Rs 5). The company received an unmodified (clean) audit opinion from statutory auditors with no going concern issues. Operating cash flow remained healthy at Rs 10,233.71 Lakhs. The company appointed new internal and cost auditors. One subsidiary was liquidated during the year. Segment-wise, Chemicals dominates with Rs 82,955.50 Lakhs revenue while Pharma segment reported a loss.

Likely market impact

The strong 46% revenue growth and 19% PAT growth indicate robust operational performance driven by the Chemicals segment. The clean audit and healthy cash flows are positive signals for shareholders. The dividend payout demonstrates management confidence.